Avidity Partners Management’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-890,000	Closed	-$1.84M	–	76
2024 Q3	$1.84M	Buy	+890,000	New	+$1.84M	0.09%	77